Crossmark

Glycoproteomics Landscape of Asymptomatic and Symptomatic Human Alzheimer’s Disease Brain

Crossref DOI link: https://doi.org/10.1016/j.mcpro.2022.100433

Published Print: 2022-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Suttapitugsakul, Suttipong

Stavenhagen, Kathrin https://orcid.org/0000-0001-9322-2945
Donskaya, Sofia https://orcid.org/0000-0002-3175-1822
Bennett, David A.

Mealer, Robert G. https://orcid.org/0000-0001-5963-2836
Seyfried, Nicholas T.

Cummings, Richard D. https://orcid.org/0000-0002-8918-5034
Funding

Funding for this research was provided by:

National Institutes of Health (R01AG061800)

National Institutes of Health (RF1AG057470)

National Institutes of Health (RF1AG057471)

National Institutes of Health (RF1AG062181)
License Information

Text and Data Mining valid from 2022-12-01

Text and Data Mining valid from 2022-12-01

Version of Record valid from 2022-10-22
More Information

This article is maintained by: Elsevier

Article Title: Glycoproteomics Landscape of Asymptomatic and Symptomatic Human Alzheimer’s Disease Brain

Journal Title: Molecular & Cellular Proteomics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.mcpro.2022.100433

Content Type: article

Copyright: © 2022 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.